UBS
CASI icon

UBS’s CASI Pharmaceuticals CASI Stock Holding History

UBS’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$4K Buy
+205
New +$3.65K ﹤0.01% 9592
2014
Q2 		– Sell
-186
Closed -$3K – 10443
2014
Q1 		$3K Buy
+186
New +$3.52K ﹤0.01% 9821
2013
Q4 		– Sell
-402
Closed -$8K – 10413
2013
Q3 		$8K Buy
402
+202
+101% +$3.84K ﹤0.01% 9000
2013
Q2 		$4K Buy
+200
New +$3.88K ﹤0.01% 9386

Other funds holding CASI

WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.57B AUM 37.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

UBS's CASI Position: Q3 2014 in Review

UBS opened a new position in CASI Pharmaceuticals (CASI) in Q3 2014: 205 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #9592 among its holdings. This is a return to the name: UBS previously reported a position in CASI as recently as Q1 2014.

UBS first reported a position in CASI in Q2 2013 and has held it in 4 quarters since. The position peaked at $8K in Q3 2013. 30 funds tracked by Wall St. Rank hold CASI as of Q3 2014.

  • UBS held 205 shares of CASI Pharmaceuticals worth $4K as of Q3 2014.
  • CASI Pharmaceuticals was a new UBS position in Q3 2014.
  • CASI Pharmaceuticals made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9592 holding.
  • UBS first reported a position in CASI Pharmaceuticals in Q2 2013 and has held it in 4 quarters since.
  • UBS's CASI Pharmaceuticals position peaked at $8K in Q3 2013.
  • 30 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.